Cover Image
市場調查報告書

過敏症:全球臨床實驗檢討

Hypersensitivity Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 318340
出版日期 內容資訊 英文 536 Pages
訂單完成後即時交付
價格
Back to Top
過敏症:全球臨床實驗檢討 Hypersensitivity Global Clinical Trials Review, H2, 2017
出版日期: 2017年10月31日 內容資訊: 英文 536 Pages
簡介

本報告提供過敏症相關相關的臨床研究最新趨勢分析,提供疾病·治療方法概要,及主要已開發國家·新興國家的臨床實驗狀況,各地區、Phase、階段的進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,加上有潛力的藥劑比較等資訊,為您概述為以下內容。

目錄

  • 簡介
    • 過敏症
    • 本報告概要
  • 各地區的臨床實驗情形
    • 各國臨床實驗數量和平均實驗人數
      • 亞太地區主要5個國家的臨床實驗數量
      • 歐洲主要5個國家的臨床實驗數量
      • 北美主要國家的臨床實驗數量
      • 中東·非洲主要5個國家的臨床實驗數量
      • 中南美主要國家的臨床實驗數量
  • G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上過敏症所佔的比例
  • G7各國臨床實驗數量:Phase別
  • G7各國臨床實驗數量:各進展狀況
  • E7各國臨床實驗數量:免疫疾病治療藥臨床實驗上過敏症所佔的比例
  • E7各國臨床實驗數量:Phase別
  • E7各國臨床實驗數量:各進展狀況
  • Phase別臨床實驗數量
    • 進行中的臨床實驗:不同階段
  • 各進展狀況臨床實驗數量
  • 臨床實驗的目標的成就情形
  • 未完成的臨床實驗數量:過敏症的情況
  • 一定期間所採用的實驗對像
  • 贊助商類別的臨床實驗數量
  • 有潛力的贊助商
    • 過敏症的治療藥臨床實驗的主要參與企業
  • 有潛力的藥劑
  • 臨床實驗簡介
    • 主要企業臨床實驗概要
      • Allergy Therapeutics plc
      • GlaxoSmithKline plc
      • Merck & Co., Inc.
      • 小野藥品工業
      • Laboratorios LETI S.L.
      • United Pharmaceuticals SA
      • Sanofi
      • Procter & Gamble Srl
      • Noblewell, Inc
      • Allertein Therapeutics, LLC
    • 主要研究機關/政府臨床實驗概要
      • The National Institute of Allergy and Infectious Diseases
      • The University of North Carolina at Chapel Hill
      • Assistance Publique - Hopitaux de Paris
      • Maastricht University Medical Center
      • University Hospital Inselspital, Berne
      • Imperial College London
      • The Children's Hospital of Philadelphia
      • Isfahan University of Medical Sciences
      • Chinese University of Hong Kong
      • National Institute of Neurological Disorders and Stroke
  • 5個有代表性的臨床實驗簡介
  • 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4621CTIDB

GlobalData's clinical trial report, "Hypersensitivity Global Clinical Trials Review, H2, 2017" provides an overview of Hypersensitivity clinical trials scenario. This report provides top line data relating to the clinical trials on Hypersensitivity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Hypersensitivity to Immunology Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Hypersensitivity to Immunology Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 26
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Hypersensitivity Therapeutics Clinical Trials 31
  • Prominent Drugs 33
  • Clinical Trial Profile Snapshots 34

Appendix 534

  • Abbreviations 534
  • Definitions 534
  • Research Methodology 535
  • Secondary Research 535
  • About GlobalData 536
  • Contact Us 536
  • Source 536

List of Tables

List of Tables

  • Hypersensitivity Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Hypersensitivity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Hypersensitivity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Hypersensitivity Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Hypersensitivity Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Hypersensitivity Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
  • Hypersensitivity Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
  • Proportion of Hypersensitivity to Immunology Clinical Trials, G7 Countries (%), 2017* 16
  • Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Hypersensitivity to Immunology Clinical Trials, E7 Countries (%), 2017* 19
  • Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Hypersensitivity Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Hypersensitivity Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
  • Hypersensitivity Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
  • Hypersensitivity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
  • Hypersensitivity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28
  • Hypersensitivity Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
  • Hypersensitivity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
  • Hypersensitivity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

List of Figures

List of Figures

  • Hypersensitivity Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Hypersensitivity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Hypersensitivity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Hypersensitivity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Hypersensitivity Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Hypersensitivity Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
  • Hypersensitivity Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 15
  • Proportion of Hypersensitivity to Immunology Clinical Trials, G7 Countries (%), 2017* 16
  • Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Hypersensitivity to Immunology Clinical Trials, E7 Countries (%), 2017* 19
  • Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Hypersensitivity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Hypersensitivity Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
  • Hypersensitivity Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Hypersensitivity Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
  • Hypersensitivity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
  • Hypersensitivity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28
  • Hypersensitivity Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Hypersensitivity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Hypersensitivity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33
  • GlobalData Methodology 535
Back to Top